Heart pump auto mode tested in High-Risk procedure
NCT ID NCT07588399
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests two ways of running a temporary heart pump (Impella CP) during a high-risk procedure to open blocked heart arteries in patients with weakened heart muscle. Fifty patients will be randomly assigned to either an automatic mode that adjusts flow or a fixed lower-flow mode, with the doctor blinded to the setting. The goal is to see if the automatic mode helps complete the procedure more successfully without complications, informing a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Impella CP heart pump
What this could lead to
If successful, this could show that an automatic pump setting helps complete high-risk heart procedures more safely, guiding larger future studies.
What could go wrong
This is a small, early pilot study with only 50 patients, so results may not apply broadly. The pump itself carries risks like bleeding or vessel damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Vienna
Vienna, State of Vienna, 1090, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••